GlassScriptPhysician profile
Stephen R Ramee
NPI 1780630038
$56,128.91
in general payments reported to CMS, 2019-2025
30 companies · $5,656 in 2025
The $5,656 reported for 2025 was more than what 84% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15K · 2020: $9,579 · 2021: $1,046 · 2022: $903 · 2023: $15K · 2024: $9,315 · 2025: $5,656.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $11K · Food and Beverage: $10K · Travel and Lodging: $3,742 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $2,200 · Honoraria: $2,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $11,125.00 |
| Food and Beverage | $10,405.34 |
| Travel and Lodging | $3,742.03 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $2,200.00 |
| Honoraria | $2,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Canon Medical Systems USA, INC. | $22,132.76 | 2019-2025 | Angio Workstation Software, General Non-Equipment, Interventional Angiography System |
| Boston Scientific Corporation | $12,233.31 | 2019-2025 | Watchman |
| Edwards Lifesciences Corporation | $10,742.42 | 2019-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Evoque, Pascal |
| Shockwave Medical, INC | $2,600.29 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Medtronic, INC. | $2,036.38 | 2021-2025 | Corevalve Evolut R, Protege Rx, Symplicity G3 |
| Philips North America LLC | $1,153.90 | 2019-2024 | (Br5) Peripheral Ivus, (Az7) Lasers |
| Abbott Laboratories | $944.82 | 2021-2025 | Triclip, Navitor, Mitraclip |
| Abiomed | $916.37 | 2019-2024 | Impella |
| W. L. Gore & Associates, INC. | $690.08 | 2021-2025 | Gore Cardioform Septal Occluder |
| Janssen Pharmaceuticals, INC | $456.96 | 2020-2023 | Xarelto |
| Medtronic Vascular, INC. | $409.58 | 2019-2020 | |
| Recor Medical INC | $307.61 | 2025 | Paradise Ultrasound Renal Denervation System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $190.36 | 2023 | Lifevest |
| Inari Medical, INC. | $161.36 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Amgen INC. | $159.93 | 2021-2023 | Repatha |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Imperative Care, INC | $144.67 | 2023-2024 | Prodigy Catheter, Symphony Catheter |
| Angiodynamics, INC. | $137.87 | 2025 | Alphavac, Auryon Laser System 100-120 Vac |
| Surmodics, INC. | $133.85 | 2022 | |
| Penumbra, INC. | $124.99 | 2025 | Indigo System |
| Siemens Medical Solutions USA, INC. | $115.45 | 2023-2025 | Artis Icono Biplane, Corpath Imaging System |
| Janssen Scientific Affairs, LLC | $93.01 | 2019 | |
| Atricure, INC. | $70.97 | 2025 | Synergy Ablation System |
| E.R. Squibb & Sons, L.L.C. | $44.98 | 2021-2023 | Camzyos |
| Boehringer Ingelheim Pharmaceuticals, INC. | $38.59 | 2022-2025 | Jardiance |
| Astellas Pharma US INC | $31.20 | 2021 | |
| Terumo Medical Corporation | $16.89 | 2025 | Navicross |
| Merck Sharp & Dohme LLC | $16.45 | 2024 | Verquvo |
| Astrazeneca Pharmaceuticals LP | $15.13 | 2020 | |
| Acutus Medical, INC. | $8.73 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$5,642,836.50 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Ramee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.